Brenda Velasco - Publications

Affiliations: 
2018- Blood and Marrow Transplantation Stanford University School of Medicine, Palo Alto, CA, United States 
Website:
https://profiles.stanford.edu/brenda-velasco

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Chang CA, Bhagchandani P, Poyser J, Velasco BJ, Zhao W, Kwon HS, Meyer E, Shizuru JA, Kim SK. Curative islet and hematopoietic cell transplantation in diabetic mice without toxic bone marrow conditioning. Cell Reports. 41: 111615. PMID 36351397 DOI: 10.1016/j.celrep.2022.111615  0.719
2021 Bankova AK, Pang W, Velasco BJ, Long-Boyle JR, Shizuru JA. 5-Azacytidine depletes hematopoietic stem cells and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice. Blood Advances. PMID 34448832 DOI: 10.1182/bloodadvances.2020003841  0.387
2019 George BM, Kao KS, Kwon HS, Velasco BJ, Poyser J, Chen A, Le AC, Chhabra A, Burnett CE, Cajuste D, Hoover M, Loh KM, Shizuru JA, Weissman IL. Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance. Cell Stem Cell. PMID 31204177 DOI: 10.1016/J.Stem.2019.05.018  0.652
2005 Rodríguez L, Velasco B, García J, Martín-Henao GA. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion. 45: 1391-7. PMID 16078930 DOI: 10.1111/j.1537-2995.2005.00213.x  0.37
Show low-probability matches.